These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30666925)

  • 1. International Biological Reference Preparations for Epidemic Infectious Diseases.
    Rampling T; Page M; Horby P
    Emerg Infect Dis; 2019 Feb; 25(2):205-211. PubMed ID: 30666925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confronting the threat of bioterrorism: realities, challenges, and defensive strategies.
    Green MS; LeDuc J; Cohen D; Franz DR
    Lancet Infect Dis; 2019 Jan; 19(1):e2-e13. PubMed ID: 30340981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEPI: Driving Progress Toward Epidemic Preparedness and Response.
    Gouglas D; Christodoulou M; Plotkin SA; Hatchett R
    Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological security confronting bioterrorism].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 2002; 119(1):77-89; discussion 89-95. PubMed ID: 12197209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparedness activities and research needs in addressing emerging infectious animal and zoonotic diseases.
    Cardoen S; De Clercq K; Vanholme L; De Winter P; Thiry E; Van Huffel X
    Rev Sci Tech; 2017 Aug; 36(2):557-568. PubMed ID: 30152463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US Federal Travel Restrictions for Persons with Higher-Risk Exposures to Communicable Diseases of Public Health Concern.
    Vonnahme LA; Jungerman MR; Gulati RK; Illig P; Alvarado-Ramy F
    Emerg Infect Dis; 2017 Dec; 23(13):S108-13. PubMed ID: 29155659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing vaccines against epidemic-prone emerging infectious diseases.
    Bernasconi V; Kristiansen PA; Whelan M; Román RG; Bettis A; Yimer SA; Gurry C; Andersen SR; Yeskey D; Mandi H; Kumar A; Holst J; Clark C; Cramer JP; Røttingen JA; Hatchett R; Saville M; Norheim G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):65-73. PubMed ID: 31776599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the International Conference on Emerging Infectious Diseases US-Japan Cooperative Medical Science Program, Bangkok, 1997.
    Mahmoud AA; La Montagne J; Takeda Y
    J Infect Dis; 1998 Jan; 177(1):3-4. PubMed ID: 9419162
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends of major disease outbreaks in the African region, 2003-2007.
    Kebede S; Duales S; Yokouide A; Alemu W
    East Afr J Public Health; 2010 Mar; 7(1):20-9. PubMed ID: 21413568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2016 International meeting of the Global Virus Network.
    Akkina R; Ellerbrok H; Hall W; Hasegawa H; Kawaguchi Y; Kleanthous H; McSweegan E; Mercer N; Romanowski V; Sawa H; Vahlne A
    Antiviral Res; 2017 Jun; 142():21-29. PubMed ID: 28315708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for global R&D coordination for infectious diseases with epidemic potential.
    Kieny MP; Rottingen JA; Farrar J; ;
    Lancet; 2016 Jul; 388(10043):460-1. PubMed ID: 27507751
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of generic roadmaps for the strategic coordination of global research into infectious diseases of animals and zoonoses.
    Entrican G; Charlier J; Dalton L; Messori S; Sharma S; Taylor R; Morrow A
    Transbound Emerg Dis; 2021 May; 68(3):1513-1520. PubMed ID: 32896967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak response as an essential component of vaccine development.
    Hatchett R; Lurie N
    Lancet Infect Dis; 2019 Nov; 19(11):e399-e403. PubMed ID: 31256955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases: considerations for the 21st century.
    Fauci AS
    Clin Infect Dis; 2001 Mar; 32(5):675-85. PubMed ID: 11229834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling epidemics with transmissible vaccines.
    Nuismer SL; May R; Basinski A; Remien CH
    PLoS One; 2018; 13(5):e0196978. PubMed ID: 29746504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modernising epidemic science: enabling patient-centred research during epidemics.
    Rojek AM; Horby PW
    BMC Med; 2016 Dec; 14(1):212. PubMed ID: 27989237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Global Collaboration Can Improve the Medical Countermeasure Life Cycle for Infectious Disease Outbreaks.
    Swenson J; Disbrow G; Johnson RA
    J Infect Dis; 2024 Jul; 230(1):e1-e3. PubMed ID: 39052706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating infectious disease epidemics through China's Belt and Road Initiative.
    Chen J; Bergquist R; Zhou XN; Xue JB; Qian MB
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007107. PubMed ID: 30998687
    [No Abstract]   [Full Text] [Related]  

  • 20. World Health Organization strategy for emerging infectious diseases.
    LeDuc JW
    JAMA; 1996 Jan 24-31; 275(4):318-20. PubMed ID: 8544274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.